Can Laser or Light Treatment Be Used With Eczema or Psoriasis?
By Dr. Iryna Lazuk, MD — Physician-led perspective from Lazuk Esthetics in Alpharetta, Georgia.
Direct answer: Sometimes, but the diagnosis alone is not a yes or no. I consider whether eczema or psoriasis is active, the treatment area, skin type, history of flaring after injury, current medications, infection risk, pigment behavior, device and settings, goal, and follow-up. A 2026 systematic review found generally favorable outcomes in selected inflammatory dermatoses, but the evidence was heterogeneous and serious worsening, though uncommon, was not impossible.
“Sensitive skin” is a description. Eczema and psoriasis are diseases. A device plan should know the difference.
What did the systematic review find?
Researchers reviewed 57 studies involving more than 900 patients across several inflammatory dermatoses. The strongest evidence was in psoriasis and lichen sclerosus, with mostly localized, temporary adverse effects and rare reports of worsening or Koebnerization.
The limitations matter: studies varied by disease, device, indication, protocol, and quality, and many were small or nonrandomized. “Generally tolerated in selected patients” is not permission to apply one cosmetic laser protocol to every inflamed skin condition.
What would change my recommendation?
Active rash, broken skin, infection, recent flare, poor disease control, a strong Koebner history, pigment instability, new medication, or uncertainty about the diagnosis can all move the answer toward waiting. The device wavelength, energy, density, cooling, passes, and purpose also change risk.
I would separate treatment of the disease from treatment of a cosmetic concern. A light device used therapeutically for psoriasis is not the same decision as elective resurfacing over psoriasis-prone skin.
What is Koebnerization?
The Koebner phenomenon is the appearance of lesions of a disease such as psoriasis at sites of skin injury. Needling, burns, friction, or other trauma may act as triggers in susceptible people. A prior history does not predict every outcome, but it belongs in the consent and settings discussion.
Pigment change also matters, especially in skin of color or after inflammation. The absence of a flare does not guarantee the absence of post-inflammatory hyperpigmentation.
When would I not recommend treatment?
I would not treat through an unexplained rash, active infection, open skin, unstable disease, or a lesion that needs diagnosis. I would also wait when the patient cannot protect the area, complete aftercare, or return if symptoms change.
The no-treatment option may be disease stabilization, barrier repair, sun protection, or observing whether the cosmetic concern remains once inflammation settles.
How would I plan this in Alpharetta?
Fall can offer a more manageable recovery window, but lower heat does not remove ultraviolet exposure, pollen, outdoor activity, or event pressure. The useful local question is whether skin is calm and follow-up is accessible, not whether the calendar says “laser season.”
Review the decision process in Our Approach before using a device name as the starting point.
Frequently asked questions
Can laser trigger a psoriasis flare?
It can in susceptible patients, including through Koebnerization, although selected therapeutic laser protocols may also help psoriasis.
Can I treat over active eczema?
Elective treatment over active, broken, infected, or poorly controlled eczema is generally a reason to pause and reassess.
Does a patch test guarantee safety?
No. It may add information but cannot reproduce every setting, area, exposure, or delayed response.
Do biologic medications change candidacy?
They may change infection, disease-control, or coordination considerations; review the exact medication with the treating clinicians.
Is LED the same as laser?
No. Light source, wavelength, energy, penetration, heat, indication, and evidence differ.
Can laser worsen pigmentation after eczema?
Inflammation and device injury can contribute to post-inflammatory hyperpigmentation, especially when skin is active or UV protection is poor.
What should I report after treatment?
Report spreading redness, increasing pain, blistering, drainage, fever, new plaques, or unexpected pigment change promptly.
Follow Dr. Lazuk
Dr. Iryna Lazuk is the physician co-founder of Lazuk Esthetics and Dr. Lazuk Cosmetics. I evaluate anatomy, skin behavior, health context, evidence, timing, maintenance burden, and whether waiting is the better intervention.
Contact
Lazuk Esthetics | 4380 Kimball Bridge Rd, Alpharetta, GA 30022 | Concierge Service: (770) 744-3146
Medical disclaimer
This article is educational and does not diagnose a condition or establish treatment candidacy. Medication and procedure decisions require individualized evaluation by an appropriately qualified clinician.
Comments